The Role of Chemotherapy Status, Absolute Lymphocyte Count and Neutrophil Lymphocyte Ratio as Biomarkers of Candidiasis in Lung Cancer Patients

Muhamad Yusuf Musthafa, Iin Noor Chozin, Ungky Agus Setyawan, Teguh Wahyu Sardjono, Noorhamdani AS

Abstract


Background: Gradually, fungal infections are growing and have become a medical concern. Candida species are one of the most common pathogens in immunocompromised patients, such as those with lung cancer causing invasive fungal disease. Early diagnosis of candidiasis is critical for patient care in lung cancer patients. Anti-mannan IgM and IgG biomarkers are used to diagnose candidiasis. This study aims to determine the relationship between chemotherapy status, absolute lymphocyte count, and neutrophil-lymphocyte ratio to antimannan IgM and IgG.

Methods: A correlative analytic cross-sectional study was conducted on 37 lung cancer patients with positive candida sputum cultures in Dr. Saiful Anwar Malang Hospital. The 37 patients were examined for total lymphocyte level, neutrophil-lymphocyte ratio, anti-mannan IgM, and IgG. Data analysis used a contingency coefficient to determine the relationship between chemotherapy status, absolute lymphocyte count, and neutrophil-lymphocyte ratio to anti-mannan IgM and IgG.

Results: This study showed a positive correlation between chemotherapy status with anti-mannan IgM and IgG, although insignificant (p>0.05). However, there was a significant correlation between total lymphocytes and anti-mannan IgG (p=0.000;α=0.05) and between neutrophil-lymphocyte ratio and antimannan IgM (p=0.004; α=0.05).

Conclusion: The study revealed that chemotherapy status, absolute lymphocyte count, and neutrophil-lymphocyte ratio could be a biomarker of candidiasis, so lung cancer patients with a history of chemotherapy, lymphopenia, and increased neutrophil-lymphocyte ratio should consider receiving antifungals earlier.

 


Keywords


Antimannan antibodies; candidasis; lung cancer

Full Text:

PDF

References


Li F, Yu X, Ye L, Zhou G, Wang L, Luo Y. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis. Med Mycol. 2019;57(8):976–86.

Pitarch A, Nombela C, Gil C. Diagnosis of invasive candidiasis: From gold standard methods to promising leading-edge technologies. Curr Top Med Chem. 2018;18(16):1375–92.

Netea MG, Joosten LAB, Van Der Meer JWM, Kullberg BJ, Van De Veerdonk FL. Immune defence against Candida fungal infections. Nature Reviews Immunology 2015 15:10. 2015;15(10):630–42.

Alves J, Palma P, Azevedo D, Rello J. Candidemia in the patient with malignancy. https://doi.org/101080/2154833120181508290. 2018;46(5):246–52.

Gebremeskel S, Johnston B. Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies. Oncotarget. 2015;6(39):41600–19.

Wang K, Luo Y, Zhang W, Xie S, Yan P, Liu Y, et al. Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection. Mycoses. 2020;63(2):181–8.

Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605–44.

Pinzon-Charry A, Maxwell T, López JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol. 2005;83(5):451–61.

Koga M, Koibuchi T, Kikuchi T, Nakamura H, Miura T, Iwamoto A, et al. Kinetics of serum β-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS. Intern Med. 2011;50(13):1397–401.

Traktama DO, Sufiawati I. Keparahan mukositis oral pada pasien kanker kepala leher akibat kemoterapi dan/atau radioterapi. Majalah Kedokteran Gigi Indonesia. 2018;4(1):52–63.

Elluru SR, Kaveri S V., Bayry J. The protective role of immunoglobulins in fungal infections and inflammation. Semin Immunopathol. 2015;37(2):187–97.

Meshaal MS, Nagi A, Eldamaty A, Elnaggar W, Gaber M, Rizk H. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE). The Egyptian Heart Journal. 2019;71:13.




DOI: https://doi.org/10.36497/jri.v43i3.518

Refbacks

  • There are currently no refbacks.




Copyright (c) 2023 Muhamad Yusuf Musthafa, Iin Noor Chozin, Ungky Agus Setyawan, Teguh Wahyu Sardjono, Noorhamdani AS


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter